Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ

Watchlist Manager
Eckert & Ziegler Strahlen und Medizintechnik AG Logo
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
Watchlist
Price: 59.15 EUR 0.6% Market Closed
Market Cap: 1.3B EUR

During the last 3 months Eckert & Ziegler Strahlen und Medizintechnik AG insiders have not bought any shares, and have not sold any shares. The stock price has increased by 12% over this period (open performance analysis).

The last transaction was made on Mar 25, 2024 by Eckert Wagniskapital Und Frã¼Hphasenfinanzierung Gmbh , who bought 247.7k EUR worth of EUZ shares.

Last Transactions:
Eckert Wagniskapital Und Frã¼Hphasenfinanzierung Gmbh
€+247.7k
Eckert, Dr. Andreas
Chairman of the Board
€-247.7k
Eckert Wagniskapital Und Frã¼Hphasenfinanzierung Gmbh
€+1.5m
Eckert, Dr. Andreas
Chairman of the Board
€-1.5m
Perschmann, Frank
Chairman of the Supervisory Board
€+16.6k
Bouterfa, Dr. Hakim
Chairman of the Supervisory Board
€+124.8k
Eckert Wagniskapital Und Frã¼Hphasenfinanzierung Gmbh
Managing Director
€+1.4m
Maennig, Prof. Dr. Wolfgang
Supervisory Board Member
€+72.8k
Perschmann, Frank
Chairman of the Supervisory Board
€+19.5k
Maennig, Prof. Dr. Wolfgang
Supervisory Board Member
€+510.2k
Hasselmann, Dr. Harald
Member of the Executive Board
€+99.9k
View All Transactions

During the last 3 months Eckert & Ziegler Strahlen und Medizintechnik AG insiders have not bought any shares, and have not sold any shares. The stock price has increased by 12% over this period (open performance analysis).

The last transaction was made on Mar 25, 2024 by Eckert Wagniskapital Und Frã¼Hphasenfinanzierung Gmbh , who bought 247.7k EUR worth of EUZ shares.

Sold
0-3
months
0 EUR
0
3-6
months
0 EUR
0
6-9
months
0 EUR
0
9-12
months
0 EUR
0
Bought
0-3
months
No Insider Transactions
0
0 EUR
3-6
months
No Insider Transactions
0
0 EUR
6-9
months
No Insider Transactions
0
0 EUR
9-12
months
No Insider Transactions
0
0 EUR

Eckert & Ziegler Strahlen und Medizintechnik AG
Insider Trading Chart

Eckert & Ziegler Strahlen und Medizintechnik AG
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Eckert & Ziegler Strahlen und Medizintechnik AG
Last Insider Transactions

Global
Insiders Monitor

Eckert & Ziegler Strahlen und Medizintechnik AG
Glance View

Market Cap
1.2B EUR
Industry
Health Care

Eckert & Ziegler Strahlen- und Medizintechnik AG engages in the provision of isotope technology for medical, scientific, and industrial use. The company is headquartered in Berlin, Berlin and currently employs 866 full-time employees. The company went IPO on 2008-02-25. The firm operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.

EUZ Intrinsic Value
58.1 EUR
Overvaluation 2%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top